4.7 Article

Distinguishing early and late brain aging from the Alzheimer's disease spectrum: consistent morphological patterns across independent samples

期刊

NEUROIMAGE
卷 158, 期 -, 页码 282-295

出版社

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.neuroimage.2017.06.070

关键词

Alzheimer's disease; Alzheimer's disease spectrum; Early and late aging; Linked independent component analysis; Machine learning

资金

  1. European Commission's 7th Framework Programme [602450]
  2. Research Council of Norway [213837, 223273, 204966/F20]
  3. South-Eastern Norway Regional Health Authority [2013123, 2014097, 2015073, 2016083]
  4. Norwegian Health Association's Dementia Research Program
  5. KG Jebsen Foundation
  6. Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant) [U01 AG024904]
  7. DOD ADNI (Department of Defense) [W81XWH-12-2-0012]
  8. National Institute on Aging
  9. National Institute of Biomedical Imaging and Bioengineering
  10. AbbVie
  11. Alzheimer's Association
  12. Alzheimer's Drug Discovery Foundation
  13. Araclon Biotech
  14. BioClinica, Inc.
  15. Biogen
  16. Bristol-Myers Squibb Company
  17. CereSpir, Inc.
  18. Cogstate
  19. Eisai Inc.
  20. Elan Pharmaceuticals, Inc.
  21. Eli Lilly and Company
  22. EuroImmun
  23. EuroImmun
  24. F. Hoffmann-La Roche Ltd
  25. GE Healthcare
  26. IXICO Ltd.
  27. Janssen Alzheimer Immunotherapy Research & Development, LLC.
  28. Johnson & Johnson Pharmaceutical Research & Development LLC.
  29. Lumosity
  30. Lundbeck
  31. Merck Co., Inc.
  32. Meso Scale Diagnostics, LLC.
  33. NeuroRx Research
  34. Neurotrack Technologies
  35. Novartis Pharmaceuticals Corporation
  36. Pfizer Inc.
  37. Piramal Imaging
  38. Servier
  39. Takeda Pharmaceutical Company
  40. Transition Therapeutics
  41. Canadian Institutes of Health Research
  42. Genentech, Inc.

向作者/读者索取更多资源

Alzheimer's disease (AD) is a debilitating age-related neurodegenerative disorder. Accurate identification of individuals at risk is complicated as AD shares cognitive and brain features with aging. We applied linked independent component analysis (LICA) on three complementary measures of gray matter structure: cortical thickness, area and gray matter density of 137 AD, 78 mild (MCI) and 38 subjective cognitive impairment patients, and 355 healthy adults aged 18-78 years to identify dissociable multivariate morphological patterns sensitive to age and diagnosis. Using the lasso classifier, we performed group classification and prediction of cognition and age at different age ranges to assess the sensitivity and diagnostic accuracy of the LICA patterns in relation to AD, as well as early and late healthy aging. Three components showed high sensitivity to the diagnosis and cognitive status of AD, with different relationships with age: one reflected an anterior-posterior gradient in thickness and gray matter density and was uniquely related to diagnosis, whereas the other two, reflecting widespread cortical thickness and medial temporal lobe volume, respectively, also correlated significantly with age. Repeating the LICA decomposition and between-subject analysis on ADNI data, including 186 AD, 395 MCI and 220 age-matched healthy controls, revealed largely consistent brain patterns and clinical associations across samples. Classification results showed that multivariate LICA-derived brain characteristics could be used to predict AD and age with high accuracy (area under ROC curve up to 0.93 for classification of AD from controls). Comparison between classifiers based on feature ranking and feature selection suggests both common and unique feature sets implicated in AD and aging, and provides evidence of distinct age-related differences in early compared to late aging.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据